TITLE

CORRECTION

PUB. DATE
December 2006
SOURCE
Gut;Dec2006, Vol. 55 Issue 12, p1824
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction notice
ABSTRACT
A correction to the article "Unfavorable Prognosis Associated with K-ras Gene Mutation in Pancreatic Cancer Surgical Margins" that was published in the 2006 issue is presented.
ACCESSION #
23512289

 

Related Articles

  • Multimodality staging optimizes resectability in patients... Awad, Samir S.; Colletti, Lisa // American Surgeon;Jul1997, Vol. 63 Issue 7, p634 

    Evaluates the case of consecutive patients with histologically proven pancreatic or ampullary adenocarcinoma related between 1992 and 1996. Patients and methods used in the study; Calculations of sensitivity, specificity and predictive values of resectability and unresectability; Locations of...

  • Evaluation of a Serologic Marker, CA19-9, in the Diagnosis of Pancreatic Cancer. Pleskow, Douglas K.; Berger, Harvey J.; Gyves, John; Allen, Elaine; McLean, Arlene; Podotsky, Daniel K. // Annals of Internal Medicine;5/1/89, Vol. 110 Issue 9, p704 

    Presents a study that determined the utility of the serologic marker CA19-9 in the diagnosis of pancreatic cancer in patients suspected of having a pancreatic disorder. Methodology used in the study; Discussion on the results of the study; Medical care reports.

  • Two microRNA diagnostic panels may detect pancreatic cancer.  // Hem/Onc Today;3/10/2014, Vol. 15 Issue 5, p19 

    The article discusses research being done on the use of microRNA diagnostic panels in patients with pancreatic cancer, which references a study by N. A. Schultz in a 2014 issue of the "Journal of the American Medical Association."

  • Novel immunoassay detected early stage pancreatic cancer. Sticca, Robert P. // Hem/Onc Today;2/10/2010, Vol. 11 Issue 3, p1 

    The article reports on the findings of a study presented at the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida which claimed that a novel immunoassay that identifies and quantifies blood levels of the PAM4 protein may detect early-stage pancreatic cancer.

  • Coffee consumption and pancreatic cancer: temporal and spatial correlation. Benarde, Melvin A.; Weiss, William // British Medical Journal (Clinical Research Edition);2/6/1982, Vol. 284 Issue 6313, p400 

    Examines the correlation between coffee consumption and pancreatic cancer in the United States. Data on coffee consumption; Differences on the birth cohort cancer curves by race and sex; Utilization of Pearson correlation coefficient to describe the degree of relationship between the two variables.

  • Early screening for pancreatic and ovarian cancer. Simon, Richard; R.M.D. // Cortlandt Forum;9/25/95, Vol. 8 Issue 9, p98 

    Focuses on some of the best early screening procedures to detect cancer of the pancreas and ovary in patients without symptoms. Contrast-enhanced CT scan; Duodenal endoscopic ultrasound.

  • 15 Year Old Develops Test For Pancreatic Cancer. EDABURN, PATRICK // Moderate Voice;02/07/2013, p2 

    The article reports on the development of a test by a 15-year-old man which is believed by scientists to be a useful tool in the early diagnosis of pancreatic cancer.

  • Striking arthritis in a Little League coach. Kagen, Lawrence J. // Cortlandt Forum;7/25/96, Vol. 9 Issue 7, p195 

    Presents a medical case involving a 60-year old man who was diagnosed for adenocarcinoma of the pancreas. Presentation of arthritis and synovitis; Symptoms of pancreatic tumor; Fat necrosis and inflammation; Differential diagnosis showing panniculitis and erythema nodosum.

  • Metformin/vildagliptin.  // Reactions Weekly;1/25/2014, Issue 1485, p26 

    The article presents a case study of a 68-year-old man who was diagnosed with pancreatic cancer during treatment with metformin and vildagliptin for type 2 diabetes.

  • Endoscopic Ultrasonography--Guided Fine-Needle Aspiration Biopsy of Suspected Pancreatic Cancer. Gress, Frank; Gottlieb, Klaus; Sherman, Stuart; Lehman, Glen // Annals of Internal Medicine;03/20/2001, Vol. 134 Issue 6, p459 

    Investigates the negative-yield rate of endoscopic ultrasonography-guided fine-needle aspiration (FNA) biopsies in patients with suspected pancreatic cancer. Defining criteria for pancreatic cancer; Median size of mass lesions; Likelihood ratio for negative test result; Percent prevalence of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics